Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Adopt weekly routines that promote financial health and stability. These simple practices can lead to significant improvements in your finances.
18,596 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
NWN’s Q1 2026 results reveal how the company balances growth with profitability. This analysis breaks down the number...
A focused look at Toast's Q1 2026 results and what they imply for toast (tost) 2026 earnings. Expect discussion of re...
IonQ just posted revenue that more than tripled for the third straight quarter, but the stock sold off despite the ga...
As May 14 approaches, investors weigh growth momentum, profitability, and AI competition around figma's next earnings...
The White House has tapped a former private-prison executive to head ICE on an acting basis, narrowing leadership gap...
Ford surprised markets with an upward revision to its 2026 guidance after a solid first quarter. This article breaks ...
When a fund trims its Planet Fitness position, it sends a message about risk, growth, and the path for 2026. This dee...
An activist investor is pressing for board seats in a high-stakes proxy battle at Lululemon, highlighting questions a...
Auna's Q1 2026 earnings signal a mixed yet resilient growth path. This analysis breaks down revenue, margins, and gui...
A bold AI experiment in Argentina aimed at reshaping public policy stumbled on human error and bad data. The fallout ...
As Flowers Foods eyes 2026, investors want a clear view of how the bread business can weather inflation and shifting ...